| Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease |
29 |
| A systematic review and meta-analysis of the efficacy and safety of the interleukin (IL)-12/23 and IL-17 inhibitors ustekinumab, secukinumab, ixekizumab, brodalumab, guselkumab and tildrakizumab for the treatment of moderate to severe plaque psoriasis |
24 |
| Epidemiology of mental health comorbidity in psoriasis |
15 |
| Social media in dermatology: clinical relevance, academic value, and trends across platforms |
14 |
| Psoriasis in pregnancy: case series and literature review of data concerning exposure during pregnancy to ustekinumab |
14 |
| Treatment of patients with plaque psoriasis with secukinumab in a real-life setting: a 52-week, multicenter, retrospective study in Spain |
14 |
| Efficacy of cysteamine cream in the treatment of epidermal melasma, evaluating by Dermacatch as a new measurement method: a randomized double blind placebo controlled study |
12 |
| JAK-inhibitors in dermatology: current evidence and future applications |
12 |
| Drug survival of biologic treatments in psoriasis: a systematic review |
12 |
| Targeted treatments for hidradenitis suppurativa: a review of the current literature and ongoing clinical trials |
11 |
| Lichen planopilaris: retrospective study on the characteristics and treatment of 291 patients |
10 |
| Skin microneedling plus platelet-rich plasma versus skin microneedling alone in the treatment of atrophic post acne scars: a split face comparative study |
10 |
| Real-world experience of calcipotriene and betamethasone dipropionate foam 0.005%/0.064% in the treatment of adults with psoriasis in the United States |
9 |
| The comparative efficacy of brodalumab in patients with moderate-to-severe psoriasis: a systematic literature review and network meta-analysis |
9 |
| Treatment of seborrheic dermatitis: a comprehensive review |
9 |
| Redefining the therapeutic objective in psoriatic patients candidates for biological therapy |
9 |
| Comparing the efficacy of topical hydroquinone 2% versus intradermal tranexamic acid microinjections in treating melasma: a split-face controlled trial |
9 |
| Biotin for the treatment of nail disease: what is the evidence? |
8 |
| Topical ketoconazole: a systematic review of current dermatological applications and future developments |
8 |
| Development and initial psychometric evaluation of patient-reported outcome questionnaires to evaluate the symptoms and impact of hidradenitis suppurativa |
8 |
| Psoriasis-associated cutaneous pain: etiology, assessment, impact, and management |
8 |
| Risk factors for positive margins after wide local excision of cutaneous squamous cell carcinoma |
7 |
| Dermatological indications for the use of isotretinoin beyond acne |
7 |
| Defining and treating moderate plaque psoriasis: a dermatologist survey |
7 |
| Fractional carbon dioxide laser assisted delivery of topical tazarotene versus topical tioconazole in the treatment of onychomycosis |
7 |
| New and emerging targeted systemic therapies: a new era for atopic dermatitis |
7 |
| Platelet-rich plasma is a useful therapeutic option in melasma |
7 |
| Effectiveness of etanercept in children with plaque psoriasis in real practice: a one-year multicenter retrospective study |
7 |
| An update on topical photodynamic therapy for clinical dermatologists |
7 |
| Systematic review of anti-drug antibodies of IL-17 inhibitors for psoriasis |
6 |
| Oral small molecules for the treatment of atopic dermatitis: a systematic review |
6 |
| Treatment of psoriasis with crisaborole |
6 |
| Selenium, zinc, copper, Cu/Zn ratio and total antioxidant status in the serum of vitiligo patients treated by narrow-band ultraviolet-B phototherapy |
6 |
| Review of the mechanism of action of coal tar in psoriasis |
6 |
| Stem cell therapy as a novel therapeutic intervention for resistant cases of alopecia areata and androgenetic alopecia |
6 |
| Electrocardiographic changes after high-dose corticosteroid pulse therapy in pemphigus patients |
5 |
| Pemphigoid gestationis: a case series and review of the literature |
5 |
| Serum YKL-40 as a potential biomarker of inflammation in psoriasis |
5 |
| Biological treatment for psoriasis and the risk of herpes zoster: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR) |
5 |
| A cross-sectional study in young adults with psoriasis: potential determining factors in quality of life, life course and work productivity |
5 |
| Biologic and small-molecule medications in the management of pyoderma gangrenosum |
5 |
| Unmet digital health service needs in dermatology patients |
5 |
| Safety and effectiveness of conventional systemic therapy and biological drugs in patients with moderate to severe psoriasis and HIV infection: a retrospective multicenter study |
5 |
| A systematic review of ustekinumab in the treatment of atopic dermatitis |
5 |
| Minimize the regular laboratory monitoring during the systemic isotretinoin treatment: data of 704 patients with acne vulgaris |
5 |
| Selenium-loaded cellulose film derived from Styela clava tunic accelerates the healing process of cutaneous wounds in streptozotocin-induced diabetic Sprague-Dawley rats |
5 |
| Treatment patterns, adherence, and persistence among psoriasis patients treated with biologics in a real-world setting, overall and by disease severity |
5 |
| Comparison of the cost-effectiveness of biologic drugs used for moderate-to-severe psoriasis treatment in the United States |
5 |
| Review of IL-17 inhibitors for psoriasis |
5 |
| A preliminary study on topical cetirizine in the therapeutic management of androgenetic alopecia |
5 |
